These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4397217)

  • 21. [Are anticholinergics indispensable in the long-term therapy of neuroleptic-induced Parkinson syndrome? A withdrawal study (author's transl)].
    Fleischhauer J
    Arzneimittelforschung; 1976; 26(6):1183-4. PubMed ID: 786315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The probenecid test in Parkinson's disease.
    Lakke JP; Korf J; Hoorntje S; Schut T; van Praag HM
    Psychiatr Neurol Neurochir; 1973; 76(2):139-46. PubMed ID: 4700931
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acute drug-induced extrapyramidal syndrome: case studies of a decade at the autonomous toxicology department of the Arcispedale].
    Torrini M; Masini E; Ledda F; Mannaioni PF
    Clin Ter; 1981 Jun; 97(6):561-85. PubMed ID: 7023804
    [No Abstract]   [Full Text] [Related]  

  • 24. Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
    Simpson GM; Amin M; Kunz-Bartholini E; Watts TP; Laska E
    Dis Nerv Syst; 1968 Jul; 29(7):478-84. PubMed ID: 4386374
    [No Abstract]   [Full Text] [Related]  

  • 25. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
    Altagracia M; Rojas P; Kravzov J; Rios C
    Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
    [No Abstract]   [Full Text] [Related]  

  • 26. [Somatic disorders during long-term drug treatment of schizophrenic patients].
    vom Brocke I
    Internist (Berl); 1974 May; 15(5):268-70. PubMed ID: 4213663
    [No Abstract]   [Full Text] [Related]  

  • 27. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MPTP model of Parkinson's disease.
    Smeyne RJ; Jackson-Lewis V
    Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
    Orzi F; Fornai F; Blandini F
    Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
    [No Abstract]   [Full Text] [Related]  

  • 30. The antiparkinson properties of amantadine in drug-induced parkinsonism.
    Kelly JT; Abuzzahab FS
    J Clin Pharmacol New Drugs; 1971; 11(3):211-4. PubMed ID: 5211353
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.
    Freeman H; Mehta IS
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):470-7. PubMed ID: 4629309
    [No Abstract]   [Full Text] [Related]  

  • 32. The basal ganglia circuits, dopamine, and ambiguous word processing: a neurobiological account of priming studies in Parkinson's disease.
    Chenery HJ; Angwin AJ; Copland DA
    J Int Neuropsychol Soc; 2008 May; 14(3):351-64. PubMed ID: 18419834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease.
    Strange PG
    Mov Disord; 1993 Jul; 8(3):263-70. PubMed ID: 8101967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of drug induced parkinsonism].
    Aquilonius S; Dolby J; Anggård E
    Lakartidningen; 1976 Feb; 73(7):511-4. PubMed ID: 1250040
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hereditary aspects of Parkinson's disease (review of the literature)].
    Atadzhanov M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(6):919-26. PubMed ID: 4584983
    [No Abstract]   [Full Text] [Related]  

  • 36. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA
    Encephale; 1973; 62(1):78-105. PubMed ID: 4718697
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of methamidoline in the treatment of parkinson-like manifestations due to neuroleptics].
    Arnone A; Parodi A
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1126-42. PubMed ID: 5143724
    [No Abstract]   [Full Text] [Related]  

  • 38. [Side effects by psychopharmacologic drugs in childhood (author's transl)].
    Rosenmayr F; Groh C
    Padiatr Padol; 1974; 9(2):144-51. PubMed ID: 4823696
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of fatal hemorrhage in the digestive tract following treatment with butapirazol].
    Kowalczuk R
    Pol Tyg Lek; 1969 Oct; 24(43):1654-5. PubMed ID: 4391021
    [No Abstract]   [Full Text] [Related]  

  • 40. [Side-effects of psychopharmaca].
    Sjöqvist F
    Nord Med; 1967 Dec; 78(50):1653-9. PubMed ID: 6073281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.